Managing relapsed myeloma: The views of patients, nurses and doctors

被引:12
|
作者
Cormican, Orlaith [1 ]
Dowling, Maura [2 ]
机构
[1] Natl Univ Ireland Galway, Galway Univ Hosp, Clin Res Facil, Canc Clin Trials Unit, Room 1-68,Newcastle Rd, Galway, Ireland
[2] Natl Univ Ireland, Sch Nursing & Midwifery, Univ Rd, Galway, Ireland
关键词
Myeloma; Qualitative; Relpased; Nurse; Doctors; Patients; QUALITY-OF-LIFE; MULTIPLE-MYELOMA; SUPPORTIVE CARE; HEMATOLOGY; EXPERIENCES; ILLNESS; HEALTH; SENSE; MODEL; END;
D O I
10.1016/j.ejon.2016.04.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The study aim was to explore whether there were differing opinions on the current management of relapsed myeloma between patients and health care professionals, a topic which has never been explored previously in the literature. Methods: This qualitative study was undertaken at a regional specialist haematology centre in Ireland. Individual interviews were undertaken with multiple myeloma patients with relapsed disease (n = 8). Three focus groups were also undertaken with haematology nurse specialists, haematology doctors and staff nurses working in a haematology day unit (n = 17). The analysis of interview data was guided by thematic analysis. Results: Two central themes were interpreted from the interview data: 'shared decision making with the expert patient' and 'an unpredictable disease journey'. Patients felt well informed regarding their illness but faced difficult decisions at times. Nurses and doctors stressed the importance of the early introduction of palliative care but acknowledged difficulties due to myeloma being unpredictable. Conclusion: Managing relapsed myeloma was fraught with complex issues. Patients developed alternative ways of coping with their disease including adopting the role of the 'expert patient', continuing to battle their disease and living with a chronic illness. Health care professionals struggle to manage the realities of a disease where the prognosis is improving. Uncertainty around patients' care and difficulties such as when 'enough is enough', continue to cause challenges. The transition to a chronic disease offers hope to patients and an opportunity for health care professionals to implement holistic care plans encouraging patients to be self proactive. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 50 条
  • [41] Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone
    Claudio Cerchione
    Lucio Catalano
    Ilaria Peluso
    Davide Nappi
    Maria Di Perna
    Dalila Salvatore
    Ilaria Migliaccio
    Marco Picardi
    Fabrizio Pane
    [J]. Supportive Care in Cancer, 2016, 24 : 4835 - 4837
  • [42] BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Michael, M.
    Bruns, I.
    Boelke, E.
    Zohren, F.
    Czibere, A.
    Safaian, N. N.
    Ncumann, F.
    Haas, R.
    Kobbe, G.
    Fenk, R.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (01) : 13 - 19
  • [43] Bendamustine in patients with relapsed or refractory multiple myeloma
    M Michael
    I Bruns
    E Bölke
    F Zohren
    A Czibere
    N N Safaian
    F Neumann
    R Haas
    G Kobbe
    R Fenk
    [J]. European Journal of Medical Research, 15
  • [44] Managing multiple myeloma in elderly patients
    Diamond, Evan
    Lahoud, Oscar B.
    Landau, Heather
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (06) : 1300 - 1311
  • [45] Clinical course of patients with relapsed multiple myeloma
    Kumar, SK
    Therneau, TM
    Gertz, MA
    Lacy, MQ
    Dispenzieri, A
    Rajkumar, SV
    Fonseca, R
    Witzig, TE
    Lust, JA
    Larson, DR
    Kyle, RA
    Greipp, PR
    [J]. MAYO CLINIC PROCEEDINGS, 2004, 79 (07) : 867 - 874
  • [46] Clinical characteristics of patients with relapsed multiple myeloma
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Niesvizky, Ruben
    Palumbo, Antonio
    [J]. CANCER TREATMENT REVIEWS, 2015, 41 (10) : 827 - 835
  • [47] Management of patients with relapsed/refractory multiple myeloma
    Ludwig, H.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 3 - 4
  • [48] DOCTORS AND NURSES
    HICKS, J
    [J]. BRITISH MEDICAL JOURNAL, 1981, 283 (6301): : 1263 - 1263
  • [49] Doctors & nurses
    Schillinger, L
    [J]. NEW YORK TIMES BOOK REVIEW, 2006, : 8 - 8
  • [50] NURSES AND DOCTORS
    HAYS, PL
    [J]. BRITISH MEDICAL JOURNAL, 1977, 1 (6062): : 714 - 715